Verde Bio Holdings Stock Current Asset
| APHD Stock | USD 0.0001 0.00 0.00% |
Verde Bio Holdings fundamentals help investors to digest information that contributes to Verde Bio's financial success or failures. It also enables traders to predict the movement of Verde Pink Sheet. The fundamental analysis module provides a way to measure Verde Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Verde Bio pink sheet.
Verde |
Verde Bio Holdings Company Current Asset Analysis
Verde Bio's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Verde Bio Current Asset | 28 K |
Most of Verde Bio's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Verde Bio Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
In accordance with the recently published financial statements, Verde Bio Holdings has a Current Asset of 28 K. This is 100.0% lower than that of the Financial Services sector and significantly higher than that of the Shell Companies industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Verde Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Verde Bio's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Verde Bio could also be used in its relative valuation, which is a method of valuing Verde Bio by comparing valuation metrics of similar companies.Verde Bio is currently under evaluation in current asset category among its peers.
Verde Fundamentals
| Return On Asset | -0.16 | |||
| Operating Margin | (0.99) % | |||
| Current Valuation | 286.8 K | |||
| Shares Outstanding | 254.04 K | |||
| Price To Earning | (0.20) X | |||
| Price To Sales | 0.94 X | |||
| Revenue | 456.04 K | |||
| Gross Profit | 11.54 K | |||
| EBITDA | (1.27 M) | |||
| Net Income | (1.58 M) | |||
| Cash And Equivalents | 126.02 K | |||
| Cash Per Share | 0.50 X | |||
| Total Debt | 1.07 M | |||
| Current Ratio | 0.10 X | |||
| Book Value Per Share | (5.54) X | |||
| Cash Flow From Operations | (177.75 K) | |||
| Earnings Per Share | (1.26) X | |||
| Number Of Employees | 11 | |||
| Beta | 0.15 | |||
| Market Capitalization | 412.81 K | |||
| Total Asset | 1.63 K | |||
| Retained Earnings | (2.43 M) | |||
| Working Capital | (958 K) | |||
| Current Asset | 28 K | |||
| Current Liabilities | 986 K | |||
| Net Asset | 1.63 K |
About Verde Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Verde Bio Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Verde Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Verde Bio Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Verde Pink Sheet
Verde Bio financial ratios help investors to determine whether Verde Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Verde with respect to the benefits of owning Verde Bio security.